This study added a new dimension to our comprehensive understanding of OAS1 in tumor initiation and progression, and provided bioinformatics evidence and experimental evidence for application of OAS1 as a target gene in clinical tumor therapy in the future. The gene discussed is OAS1; the disease is neoplasm.